# Tubule‐Derived IFN‐α Promotes GSDMD‐Mediated Macrophage Pyroptosis to Drive Renal Inflammation and Fibrosis Through JAK2/STAT2 Activation

**Authors:** Yiping Xu, Yating Wang, Siming Jiang, Yi Li, Guanglan Li, Yuchu Liu, Siyuan Li, Yiming Zhou, Qinghua Liu, Yi Zhou, Wei Chen, Hongyu Li, Haiping Mao

PMC · DOI: 10.1002/advs.202512278 · Advanced Science · 2025-12-12

## TL;DR

This study shows how kidney inflammation and scarring are driven by a feedback loop between injured cells and immune cells, offering a new target for treating chronic kidney disease.

## Contribution

The study identifies a novel STAT2/IRF9-dependent IFN-α signaling pathway linking TEC injury to macrophage pyroptosis in CKD.

## Key findings

- GSDMD is upregulated in kidney macrophages after injury and correlates with fibrosis severity in CKD.
- TEC-derived IFN-α activates the JAK2/STAT2 axis in macrophages, promoting GSDMD expression and pyroptosis.
- Blocking IFN-α reduces pyroptosis, inflammation, and fibrosis in mouse models of CKD.

## Abstract

Macrophages exhibit high plasticity in response to tubular epithelial cell (TEC) injury. Gasdermin D (GSDMD)‐mediated pyroptosis amplifies the inflammatory and fibrogenic cascade, yet its role in chronic kidney disease (CKD) remains elusive. Herein, GSDMD is upregulated in kidney macrophages following unilateral renal ischemia‐reperfusion injury (UIRI) or folic acid‐induced injury, paralleling elevated pyroptosis rates. Clinically, the active fragment GSDMD‐N localizes primarily to CD68⁺ macrophages, and its renal level positively correlates with fibrosis severity across diverse CKD etiologies, reinforcing its pathogenic relevance. Macrophage‐specific deletion of Gsdmd ameliorates pyroptosis, inflammation, and renal fibrosis in both murine models, without affecting acute tubular damage in bilateral IRI. Mechanistically, injured TECs initiate this cascade through secreted IFN‐α, which activates the IFNAR1/JAK2/STAT2 axis in macrophages​. STAT2 then forms a complex with IRF9, directly binding to the Gsdmd promoter to transcriptionally upregulate GSDMD expression. Genetic ablation of Jak2, Stat2, or Ifnar1 reduces GSDMD and GSDMD‐N levels and inhibits IL‐1β/IL‐18 secretion. Notably, administration of an IFN‐α neutralizing antibody attenuates UIRI‐induced pyroptotic macrophage, inflammation, and renal fibrosis. Collectively, the findings uncover a STAT2/IRF9‐dependent paracrine IFN‐α feedback loop that orchestrates GSDMD‐mediated pyroptosis, linking injured TECs to macrophage‐driven renal inflammation and fibrosis. Targeting this axis represents a promising strategy to halt CKD progression.

Mao and colleagues uncover a STAT2/IRF9‐dependent signaling axis through which tubular epithelial cell (TEC)‐derived IFN‐α induces gasdermin D (GSDMD)‐mediated pyroptosis in macrophages. This TEC‐macrophage feedback loop amplifies renal inflammation and fibrosis, providing mechanistic insight into the progression of chronic kidney disease and revealing a potential direction for therapeutic intervention.

## Linked entities

- **Genes:** GSDMD (gasdermin D) [NCBI Gene 79792], GSDMD (gasdermin D) [NCBI Gene 79792], JAK2 (Janus kinase 2) [NCBI Gene 3717], STAT2 (signal transducer and activator of transcription 2) [NCBI Gene 6773], IFNAR1 (interferon alpha and beta receptor subunit 1) [NCBI Gene 3454], IRF9 (interferon regulatory factor 9) [NCBI Gene 10379], IFNAR1 (interferon alpha and beta receptor subunit 1) [NCBI Gene 3454], JAK2 (Janus kinase 2) [NCBI Gene 3717], STAT2 (signal transducer and activator of transcription 2) [NCBI Gene 6773]
- **Proteins:** IFN1@ (interferon, type 1, cluster), IL1B (interleukin 1 beta), IL18 (interleukin 18)
- **Diseases:** chronic kidney disease (MONDO:0005300), renal fibrosis (MONDO:0000494)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Il18 (interleukin 18) [NCBI Gene 16173] {aka Igif, Il-18}, Gsdmd (gasdermin D) [NCBI Gene 69146] {aka 1810036L03Rik, DF5L, Dfna5l, GsdmD-1, Gsdmdc1, M2-4}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Jak2 (Janus kinase 2) [NCBI Gene 16452] {aka Fd17}, Ifnar1 (interferon (alpha and beta) receptor 1) [NCBI Gene 15975] {aka Ifar, Ifnar, Ifrc, Infar}, Irf9 (interferon regulatory factor 9) [NCBI Gene 16391] {aka Irf-9, Isgf3g, p48}, Ifna (interferon alpha complex region) [NCBI Gene 111654] {aka Ifa, Ifa8}, Cd68 (CD68 antigen) [NCBI Gene 12514] {aka Lamp4, Scard1, gp110}, Stat2 (signal transducer and activator of transcription 2) [NCBI Gene 20847] {aka 1600010G07Rik}
- **Diseases:** GSDMD-N (MESH:D014808), UIRI (MESH:D007511), Fibrosis (MESH:D005355), Renal Inflammation (MESH:D007249), acute tubular damage (MESH:D000208), CKD (MESH:D051436)
- **Chemicals:** folic acid (MESH:D005492)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12931230/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12931230/full.md

## References

57 references — full list in the complete paper: https://tomesphere.com/paper/PMC12931230/full.md

---
Source: https://tomesphere.com/paper/PMC12931230